Arterial microvascularization and breast cancer colonization in bone

Histology and Histopathology

Volumn 12, Issue 4, 1997, Pages 1145-1149

  Yoneda, T ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bone metastasis; Breast cancer; Hemodynamics; Osteoclast; Osteolysis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE METASTASIS; BREAST CANCER; CONTROLLED STUDY; HEMODYNAMICS; HISTOPATHOLOGY; MICROVASCULARIZATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; RADIODIAGNOSIS; REVIEW; TUMOR VASCULARIZATION;

ANIMALS; ARTERIES; BONE NEOPLASMS; BREAST NEOPLASMS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; REGIONAL BLOOD FLOW;

ANIMALIA;

EID: 0030764087     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Arguello F. and Cohen H.J. (1996). Structural and microenvironmental bone marrow factors involved in the pathogenesis of bone metastasis. In: Bone metastasis - Mechanisms and pathophysiology. Orr F.W. and Singh G. (eds). Chapman and Hall. Austin, pp 31-39.
2. Berrettoni B.A. and Carter J.R. (1986). Mechanisms of cancer metastasis to bone. J. Bone Joint Surg. USA 68, 308-312.
3. De Bruyn P.P.H. (1981). Structural subst4rates of bone marrow function. Semin. Hematol. 18, 179-193.
4. Ewing J. (1928). A treatise on tumors. W.B. Saunders. Philadelphia.
5. Guise T.A., Yin J.J., Taylor S.D., Kumagai Y., Dallas M., Boyce B.F., Yoneda T. and Mundy G.R. (1996). Evidence for a casual role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98, 1544-1549.
6. Hauschka P.V., Manrakos A.E., Iafrati M.D., Doleman S.E. and Klagsbrun M. (1986). Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose. J. Biol. Chem. 261, 12665-12674
7. Jee W.S.S. (1988). The skeletal tissues. In: Cell and tissue biology. 6th ed. Weiss L. (ed). Urban and Schwarzenberg. Baltimore, pp 233.
8. Mbalaviele G., Dunstan C.R., Sasaki A., Williams P.J., Mundy G.R. and Yoneda T. (1996). E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastais model. Cancer Res. 56, 4063-4070.
9. Mundy G.R. and Yoneda T. (1995). Facilitation and suppression of bone metastasis. Clin. Orthop. Relat. Res. 312, 34-44.
10. Mundy G.R. and Yoneda T. (1996). Mechanisms of bone metastasis. In: Bone metastais. mechanisms and pathophysiology. Orr F.W. and Singh G. (eds). Chapman and Hall. Austin, pp 1-12.
11. Nakai M., Mundy G.R., Williams P.J., Boyce B. and Yoneda T. (1992). A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res. 52, 5395-5399.
12. Paget S. (1889). The distribution of secondary growths in cancer of breast. Lancet 1, 571-573.
13. Sasaki A., Boyce B.F., Story B., Wright K.R., Chapman M., Boyce R., Mundy G.R. and Yoneda T. (1995). Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 55, 3551-3557.
14. Weiss L., Haydock K., Pickren J.W. and Lane W.W. (1980). Organ vascularity and metastatic frequency. Am. J. Pathol. 101, 101-114.
15. Yoneda T. (1996). Mechanisms of preferential metastasis of breast cancer to bone. Int. J. Oncol. 93, 103-109.
16. Yoneda T., Sasaki A. and Mundy G.R. (1995). Osteolytic bone disease in breast cancer. Breast Cancer Res. Treat. 32, 73-84.
17. Yoneda T., Williams P., Izbicka T., Boyce B.F. and Mundy G.R. (1994). Develpment of a model of a human tumor which causes metastatic bone lesions which are mixed osteolytic and osteoblastic. J. Bone Miner. Res. 9 (suppl. 1), S293.